Le Lézard
Classified in: Health

Redwood Scientific Technologies Inc. (OTC: RSCI) ("Redwood" or "the Company"), a pharmaceutical company, today announced a strategic shift in its product development priorities


NEW YORK, April 18, 2024 /PRNewswire/ -- Redwood Scientific Technologies Inc. (OTC: RSCI) ("Redwood" or "the Company"), a pharmaceutical company, today announced a strategic shift in its product development priorities. The New York-based firm will only focus on enhancing and expanding its nicotine replacement therapy (NRT) products, specifically TBX-FREEtm and TBX VAPE-FREEtm.

This pivotal decision follows recent findings published by the American College of Cardiology, sourced from a study conducted by the National Institute of Health. The study highlights a significant correlation between e-cigarette use and an increased risk of heart failure, underscoring the urgency for effective and safe alternatives in nicotine replacement therapy.

"Given the alarming data linking e-cigarette use to serious health risks, Redwood is committed to advancing our development of TBX-FREEtm and TBX VAPE-FREEtm products," said Jason Cardiff,  CEO of Redwood Scientific Technologies. "Our goal is clear ? to provide safer, scientifically-backed alternatives that meet the needs of consumers aiming to quit smoking without the harmful effects associated with e-cigarettes."

Redwood believes that its TBX-FREEtm and TBX VAPE-FREEtm products will be innovative solutions in the realm of nicotine replacement therapy. The company anticipates publication of double blind randomized studies before bringing these products to market.

By concentrating its resources on TBX-FREEtm and TBX VAPE-FREEtm, Redwood is positioning itself to be at the forefront of a critical market, responding proactively to the latest scientific research and public health needs.

For more information about Redwood Scientific Technologies and its products, please visit www.Redwoodsci.com

About Redwood Scientific Technologies Inc.

Redwood Scientific Technologies Inc. (OTC: RSCI) is a pharmaceutical company dedicated to developing innovative drug delivery systems. Based in New York, Redwood aims to enhance the efficacy and accessibility of pharmaceutical therapies to improve patient outcomes and quality of life.

Contact:
Name: Public Relations
Title: Communications
Email: [email protected]
Phone: (123) 456-7890

SOURCE REDWOOD SCIENTIFIC TECHNOLOGIES


These press releases may also interest you

at 11:50
Shaperon, Inc. (Kosdaq: 378800), a biotechnology company dedicated to developing innovative immunology and immuno-oncology drugs, announced it had been invited by BFC Group to participate in the upcoming 10th Annual BFC Healthcare Business...

at 11:45
Ringing in its favorite month of the year ? May's National Salad Month - Salad and Go is announcing a partnership with nationally recognized Registered Dietitian, Maya Feller. Feller is so passionate about the brand's mission to make craveable,...

at 11:32
The Bladder Cancer Advocacy Network (BCAN) is proud to announce the start of Bladder Cancer Awareness Month (BCAM), 31 days in May dedicated to spotlighting one of the most common cancers in the United States. With an estimated 725,000 people living...

at 11:32
Race2Adventure (www.race2adventure.com), the leader in international fitness travel experiences, today announced its milestone 20th adventure: a custom cruise through France and down the picturesque Rhone River. Scheduled for August 1 ? 10, 2026,...

at 11:30
This Osteoporosis Awareness and Prevention Month is particularly significant for the Bone Health and Osteoporosis Foundation (BHOF) as it celebrates its 40th year as the nation's largest health organization solely dedicated to osteoporosis and bone...

at 11:28
PCL Construction Enterprises, Inc. is pleased to announce the integration of Lyra Health, the leading provider of workforce mental health solutions, into its U.S. benefits package. With May being Mental Health Awareness Month, this addition marks a...



News published on and distributed by: